{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:08:05Z","timestamp":1768514885802,"version":"3.49.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1092597"],"award-info":[{"award-number":["1092597"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1092957"],"award-info":[{"award-number":["1092957"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Polycystic kidney disease foundation of Australia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2298-4","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T06:58:08Z","timestamp":1511420288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Standardised Outcomes in Nephrology\u2014Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3502-9837","authenticated-orcid":false,"given":"Yeoungjee","family":"Cho","sequence":"first","affiliation":[]},{"given":"Benedicte","family":"Sautenet","sequence":"additional","affiliation":[]},{"given":"Gopala","family":"Rangan","sequence":"additional","affiliation":[]},{"given":"Jonathan C.","family":"Craig","sequence":"additional","affiliation":[]},{"given":"Albert C. M.","family":"Ong","sequence":"additional","affiliation":[]},{"given":"Arlene","family":"Chapman","sequence":"additional","affiliation":[]},{"given":"Curie","family":"Ahn","sequence":"additional","affiliation":[]},{"given":"Dongping","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Helen","family":"Coolican","sequence":"additional","affiliation":[]},{"given":"Juliana Tze-Wah","family":"Kao","sequence":"additional","affiliation":[]},{"given":"Ron","family":"Gansevoort","sequence":"additional","affiliation":[]},{"given":"Ronald","family":"Perrone","sequence":"additional","affiliation":[]},{"given":"Tess","family":"Harris","sequence":"additional","affiliation":[]},{"given":"Vicente","family":"Torres","sequence":"additional","affiliation":[]},{"given":"York","family":"Pei","sequence":"additional","affiliation":[]},{"given":"Peter G.","family":"Kerr","sequence":"additional","affiliation":[]},{"given":"Jessica","family":"Ryan","sequence":"additional","affiliation":[]},{"given":"Talia","family":"Gutman","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Howell","sequence":"additional","affiliation":[]},{"given":"Angela","family":"Ju","sequence":"additional","affiliation":[]},{"given":"Karine E.","family":"Manera","sequence":"additional","affiliation":[]},{"given":"Armando","family":"Teixeira-Pinto","sequence":"additional","affiliation":[]},{"given":"Lorraine A.","family":"Hamiwka","sequence":"additional","affiliation":[]},{"given":"Allison","family":"Tong","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"issue":"3","key":"2298_CR1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1523-1755.2000.00250.x","volume":"58","author":"M Levy","year":"2000","unstructured":"Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int. 2000;58(3):925\u201343.","journal-title":"Kidney Int"},{"key":"2298_CR2","volume-title":"USRDS annual data report: atlas of chronic kidney disease and end-stage renal diseases in the United States","author":"US Renal Data System","year":"2011","unstructured":"US Renal Data System. USRDS annual data report: atlas of chronic kidney disease and end-stage renal diseases in the United States. Bethesda: National Institute of Diabetes and Digestive and Kidney Diseases; 2011."},{"key":"2298_CR3","volume-title":"39th annual report: Chapter 1. Incidence of end stage kidney disease","author":"Australia and New Zealand Dialysis and Transplant Registry","year":"2016","unstructured":"Australia and New Zealand Dialysis and Transplant Registry. 39th annual report: Chapter 1. Incidence of end stage kidney disease. Adelaide, Australia: ANZDATA; 2016."},{"issue":"6","key":"2298_CR4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","volume":"2","author":"CG Iglesias","year":"1983","unstructured":"Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935\u20131980. Am J Kidney Dis. 1983;2(6):630\u20139.","journal-title":"Am J Kidney Dis"},{"key":"2298_CR5","unstructured":"What is ADPKD? \nwww.pkdinternational.org\/what-is-pkd\/adpkd\n\n."},{"issue":"2","key":"2298_CR6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3\u00a0years. Kidney Int. 2009;76(2):149\u201368.","journal-title":"Kidney Int"},{"issue":"3","key":"2298_CR7","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","volume":"66","author":"FA Belibi","year":"2004","unstructured":"Belibi FA, Reif G, Wallace DP, Yamaguchi T, Olsen L, Li H, Helmkamp Jr GM, Grantham JJ. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int. 2004;66(3):964\u201373.","journal-title":"Kidney Int"},{"issue":"4","key":"2298_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","volume":"10","author":"VE Torres","year":"2004","unstructured":"Torres VE, Wang X, Qian Q, Somlo S, Harris PC. Gattone 2nd VH. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med. 2004;10(4):363\u20134.","journal-title":"Nat Med"},{"key":"2298_CR9","unstructured":"Borreli L. Indian man with cysts has world\u2019s largest kidneys removed, each the size of a newborn baby. \nhttp:\/\/www.medicaldaily.com\/indian-man-cysts-has-worlds-largest-kidneys-removed-each-size-newborn-baby-330448\n\n. Accessed 23 Apr 2015."},{"issue":"6","key":"2298_CR10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/ajkd.2002.33379","volume":"39","author":"GM Fick-Brosnahan","year":"2002","unstructured":"Fick-Brosnahan GM, Belz MM, McFann KK, Johnson AM, Schrier RW. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am J Kidney Dis. 2002;39(6):1127\u201334.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"2298_CR11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/qjmed\/hct082","volume":"106","author":"KM Thong","year":"2013","unstructured":"Thong KM, Ong AC. The natural history of autosomal dominant polycystic kidney disease: 30-year experience from a single centre. QJM. 2013;106(7):639\u201346.","journal-title":"QJM"},{"issue":"8","key":"2298_CR12","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2215\/CJN.00780110","volume":"5","author":"KL Lentine","year":"2010","unstructured":"Lentine KL, Xiao H, Machnicki G, Gheorghian A, Schnitzler MA. Renal function and healthcare costs in patients with polycystic kidney disease. Clin J Am Soc Nephrol. 2010;5(8):1471\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2298_CR13","doi-asserted-by":"crossref","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","volume":"29 Suppl 4","author":"EM Spithoven","year":"2014","unstructured":"Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, Areste N, de la Torre RA, Caskey F, Couchoud C, et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2014an analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant. 2014;29 Suppl 4:iv15\u201325.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"2298_CR14","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, Rentsch KM, Spanaus KS, Senn O, Kristanto P, et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med. 2010;363(9):820\u20139.","journal-title":"N Engl J Med"},{"issue":"25","key":"2298_CR15","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407\u201318.","journal-title":"N Engl J Med"},{"key":"2298_CR16","first-page":"CD010294","volume":"7","author":"D Bolignano","year":"2015","unstructured":"Bolignano D, Palmer SC, Ruospo M, Zoccali C, Craig JC, Strippoli GF. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database Syst Rev. 2015;7:CD010294.","journal-title":"Cochrane Database Syst Rev."},{"issue":"2","key":"2298_CR17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/nep.12579","volume":"21","author":"A Tong","year":"2016","unstructured":"Tong A, Tunnicliffe DJ, Lopez-Vargas P, Mallett A, Patel C, Savige J, Campbell K, Patel M, Tchan MC, Alexander SI, et al. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease. Nephrology (Carlton). 2016;21(2):122\u201332.","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"2298_CR18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.ajkd.2013.08.017","volume":"63","author":"DC Miskulin","year":"2014","unstructured":"Miskulin DC, Abebe KZ, Chapman AB, Perrone RD, Steinman TI, Torres VE, Bae KT, Braun W, Winklhofer FT, Hogan MC, et al. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1\u20134: a cross-sectional study. Am J Kidney Dis. 2014;63(2):214\u201326.","journal-title":"Am J Kidney Dis"},{"issue":"9903","key":"2298_CR19","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","volume":"382","author":"A Caroli","year":"2013","unstructured":"Caroli A, Perico N, Perna A, Antiga L, Brambilla P, Pisani A, Visciano B, Imbriaco M, Messa P, Cerutti R, et al. Effect of long-acting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet. 2013;382(9903):1485\u201395.","journal-title":"Lancet"},{"issue":"1","key":"2298_CR20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/00365590903359908","volume":"44","author":"RG Fassett","year":"2010","unstructured":"Fassett RG, Coombes JS, Packham D, Fairley KF, Kincaid-Smith P. Effect of pravastatin on kidney function and urinary protein excretion in autosomal dominant polycystic kidney disease. Scand J Urol Nephrol. 2010;44(1):56\u201361.","journal-title":"Scand J Urol Nephrol"},{"issue":"9","key":"2298_CR21","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/ndt\/gfn144","volume":"23","author":"E Higashihara","year":"2008","unstructured":"Higashihara E, Nutahara K, Horie S, Muto S, Hosoya T, Hanaoka K, Tuchiya K, Kamura K, Takaichi K, Ubara Y, et al. The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD. Nephrol Dial Transplant. 2008;23(9):2847\u201352.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2298_CR22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","volume":"68","author":"P Ruggenenti","year":"2005","unstructured":"Ruggenenti P, Remuzzi A, Ondei P, Fasolini G, Antiga L, Ene-Iordache B, Remuzzi G, Epstein FH. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int. 2005;68(1):206\u201316.","journal-title":"Kidney Int"},{"key":"2298_CR23","unstructured":"Autosomal Dominant Polycystic Kidney Disease Impact Scale (ADPKD-IS). \nhttps:\/\/eprovide.mapi-trust.org\/instruments\/autosomal-dominant-polycystic-kidney-disease-impact-scale\n\n."},{"key":"2298_CR24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1745-6215-13-132","volume":"13","author":"PR Williamson","year":"2012","unstructured":"Williamson PR, Altman D, Blazeby JM, Clarke M, Devane D, Gargon E, Tugwell P. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13:132.","journal-title":"Trials."},{"issue":"7","key":"2298_CR25","doi-asserted-by":"crossref","first-page":"e66844","DOI":"10.1371\/journal.pone.0066844","volume":"8","author":"K Dwan","year":"2013","unstructured":"Dwan K, Gamble C, Williamson PR, Kirkham JJ, Reporting BG. Systematic review of the empirical evidence of study publication bias and outcome reporting bias\u2014an updated review. PLoS One. 2013;8(7):e66844.","journal-title":"PLoS One"},{"key":"2298_CR26","doi-asserted-by":"crossref","first-page":"d7202","DOI":"10.1136\/bmj.d7202","volume":"344","author":"B Hart","year":"2012","unstructured":"Hart B, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ. 2012;344:d7202.","journal-title":"BMJ."},{"key":"2298_CR27","doi-asserted-by":"crossref","first-page":"g6501","DOI":"10.1136\/bmj.g6501","volume":"349","author":"P Saini","year":"2014","unstructured":"Saini P, Loke YK, Gamble C, Altman DG, Williamson PR, Kirkham JJ. Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews. BMJ. 2014;349:g6501.","journal-title":"BMJ."},{"issue":"9912","key":"2298_CR28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(13)62229-1","volume":"383","author":"I Chalmers","year":"2014","unstructured":"Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gulmezoglu AM, Howells DW, Ioannidis JP, Oliver S. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156\u201365.","journal-title":"Lancet"},{"key":"2298_CR29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s13063-015-0913-9","volume":"16","author":"JJ Kirkham","year":"2015","unstructured":"Kirkham JJ, Gorst S, Altman DG, Blazeby J, Clarke M, Devane D, Gargon E, Williamson PR, Group C-S. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol). Trials. 2015;16:373.","journal-title":"Trials."},{"issue":"1","key":"2298_CR30","doi-asserted-by":"crossref","first-page":"e1000393","DOI":"10.1371\/journal.pmed.1000393","volume":"8","author":"IP Sinha","year":"2011","unstructured":"Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS Med. 2011;8(1):e1000393.","journal-title":"PLoS Med"},{"key":"2298_CR31","unstructured":"Boers M, Kirwan JR, Tugwell P, Beaton D, Bingham CO, Conaghan PG. The OMERACT handbook. Ottawa: OMERACT; 2014. \nhttps:\/\/www.omeract.org\/pdf\/OMERACT_Handbook.pdf\n\n."},{"issue":"7","key":"2298_CR32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","volume":"67","author":"M Boers","year":"2014","unstructured":"Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, Conaghan PG. Bingham 3rd CO, Brooks P, Landewe R, et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol. 2014;67(7):745\u201353.","journal-title":"J Clin Epidemiol"},{"key":"2298_CR33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/1745-6215-14-324","volume":"14","author":"JJ Kirkham","year":"2013","unstructured":"Kirkham JJ, Boers M, Tugwell P, Clarke M, Williamson PR. Outcome measures in rheumatoid arthritis randomised trials over the last 50\u00a0years. Trials. 2013;14:324.","journal-title":"Trials."},{"key":"2298_CR34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-6215-14-21","volume":"14","author":"JJ Kirkham","year":"2013","unstructured":"Kirkham JJ, Gargon E, Clarke M, Williamson PR. Can a core outcome set improve the quality of systematic reviews? A survey of the Co-ordinating Editors of Cochrane Review Groups. Trials. 2013;14:21.","journal-title":"Trials"},{"key":"2298_CR35","doi-asserted-by":"crossref","first-page":"j2262","DOI":"10.1136\/bmj.j2262","volume":"357","author":"JJ Kirkham","year":"2017","unstructured":"Kirkham JJ, Clarke M, Williamson PR. A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis. BMJ. 2017;357:j2262.","journal-title":"BMJ"},{"key":"2298_CR36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1745-6215-15-247","volume":"15","author":"CA Prinsen","year":"2014","unstructured":"Prinsen CA, Vohra S, Rose MR, King-Jones S, Ishaque S, Bhaloo Z, Adams D, Terwee CB. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a \u2018core outcome set\u2019. Trials. 2014;15:247.","journal-title":"Trials"},{"key":"2298_CR37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1745-6215-8-39","volume":"8","author":"M Clarke","year":"2007","unstructured":"Clarke M. Standardising outcomes for clinical trials and systematic reviews. Trials. 2007;8:39.","journal-title":"Trials."},{"issue":"4","key":"2298_CR38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jorc.12144","volume":"41","author":"N Evangelidis","year":"2015","unstructured":"Evangelidis N, Craig JC, Tong A, Committee SE. Investigators. Standardised outcomes in nephrology\u2014haemodialysis (SONG-HD): using the Delphi method to gain consensus on core outcomes for haemodialysis trials. J Ren Care. 2015;41(4):211\u20132.","journal-title":"J Ren Care"},{"key":"2298_CR39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s13063-015-0895-7","volume":"16","author":"A Tong","year":"2015","unstructured":"Tong A, Manns B, Hemmelgarn B, Wheeler DC, Tugwell P, Winkelmayer WC, van Biesen W, Crowe S, Kerr PG, Polkinghorne KR, et al. Standardised outcomes in nephrology\u2014haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis. Trials. 2015;16:364.","journal-title":"Trials."},{"issue":"1","key":"2298_CR40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.ajkd.2016.05.022","volume":"69","author":"A Tong","year":"2017","unstructured":"Tong A, Manns B, Hemmelgarn B, Wheeler DC, Evangelidis N, Tugwell P, Crowe S, Van Biesen W, Winkelmayer WC, O'Donoghue D, et al. Establishing core outcome domains in hemodialysis: report of the standardized outcomes in nephrology\u2014hemodialysis (SONG-HD) consensus workshop. Am J Kidney Dis. 2017;69(1):97\u2013107.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2298_CR41","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/TXD.0000000000000593","volume":"2","author":"A Tong","year":"2016","unstructured":"Tong A, Budde K, Gill J, Josephson MA, Marson L, Pruett TL, Reese PP, Rosenbloom D, Rostaing L, Warrens AN, et al. Standardized outcomes in nephrology\u2014transplantation: a global initiative to develop a core outcome set for trials in kidney transplantation. Transplant Direct. 2016;2(6):e79.","journal-title":"Transplant Direct"},{"key":"2298_CR42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s13063-016-1528-5","volume":"17","author":"A Tong","year":"2016","unstructured":"Tong A, Samuel S, Zappitelli M, Dart A, Furth S, Eddy A, Groothoff J, Webb NJ, Yap HK, Bockenhauer D, et al. Standardised Outcomes in Nephrology\u2014Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease. Trials. 2016;17:401.","journal-title":"Trials."},{"key":"2298_CR43","volume-title":"The SONG handbook, vol. 1.0","author":"Initiative. S","year":"2017","unstructured":"Initiative. S. The SONG handbook, vol. 1.0. Sydney: SONG Initiative; 2017."},{"issue":"9","key":"2298_CR44","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJMsa1012065","volume":"364","author":"DA Zarin","year":"2011","unstructured":"Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database\u2014update and key issues. N Eng J Med. 2011;364(9):852\u201360.","journal-title":"N Eng J Med"},{"issue":"6","key":"2298_CR45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/j.ackd.2016.11.008","volume":"23","author":"J Samuels","year":"2016","unstructured":"Samuels J. Use of surrogate outcomes in nephrology research. Adv Chronic Kidney Dis. 2016;23(6):363\u20136.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"9","key":"2298_CR46","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1681\/ASN.2014040396","volume":"26","author":"M Jun","year":"2015","unstructured":"Jun M, Turin TC, Woodward M, Perkovic V, Lambers Heerspink HJ, Manns BJ, Tonelli M, Hemmelgarn BR. Assessing the validity of surrogate outcomes for ESRD: a meta-analysis. J Am Soc Nephrol. 2015;26(9):2289\u2013302.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2298_CR47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2125.2005.02435.x","volume":"59","author":"JK Aronson","year":"2005","unstructured":"Aronson JK. Biomarkers and surrogate endpoints. Br J Clin Pharmacol. 2005;59(5):491\u20134.","journal-title":"Br J Clin Pharmacol"},{"key":"2298_CR48","volume-title":"Developing a protocol for observational comparative effectiveness research: a user\u2019s guide","author":"P Velentgas","year":"2013","unstructured":"Velentgas P, Dreyer NA, Wu AW. Chapter 6: Outcome definition and measurements. In: Velentgas P, Dreyer NA, Nourjah P, editors. Developing a protocol for observational comparative effectiveness research: a user\u2019s guide. Rockville: Agency for Healthcare Research and Quality (US); 2013."},{"key":"2298_CR49","first-page":"1","volume-title":"Biomarkers and surrogate endpoints","author":"NIH Definitions Working Group","year":"2000","unstructured":"NIH Definitions Working Group. Biomarkers and surrogate endpoints in clinical research: definitions and conceptual model. In: Downing GJ, editor. Biomarkers and surrogate endpoints. Amsterdam: Elsevier; 2000. p. 1\u20139."},{"issue":"6","key":"2298_CR50","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.bjc.6603662","volume":"96","author":"J Corner","year":"2007","unstructured":"Corner J, Wright D, Hopkinson J, Gunaratnam Y, McDonald JW, Foster C. The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study. Br J Cancer. 2007;96(6):875\u201381.","journal-title":"Br J Cancer"},{"issue":"7001","key":"2298_CR51","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","volume":"311","author":"J Jones","year":"1995","unstructured":"Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311(7001):376\u201380.","journal-title":"BMJ"},{"key":"2298_CR52","volume-title":"Consensus development methods. Qualitative research in health care","author":"N Black","year":"2006","unstructured":"Black N. Consensus development methods. Qualitative research in health care. Malden: Blackwell; 2006."},{"issue":"2","key":"2298_CR53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2012.02.339","volume":"60","author":"M Howell","year":"2012","unstructured":"Howell M, Tong A, Wong G, Craig JC, Howard K. Important outcomes for kidney transplant recipients: a nominal group and qualitative study. Am J Kidney Dis. 2012;60(2):186\u201396.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2298_CR54","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/j.ajkd.2016.02.037","volume":"68","author":"R Urquhart-Secord","year":"2016","unstructured":"Urquhart-Secord R, Craig JC, Hemmelgarn B, Tam-Tham H, Manns B, Howell M, Polkinghorne KR, Kerr PG, Harris DC, Thompson S, et al. Patient and caregiver priorities for outcomes in hemodialysis: an international nominal group technique study. Am J Kidney Dis. 2016;68(3):444\u201354.","journal-title":"Am J Kidney Dis"},{"key":"2298_CR55","doi-asserted-by":"crossref","first-page":"a1035","DOI":"10.1136\/bmj.a1035","volume":"337","author":"A Kuper","year":"2008","unstructured":"Kuper A, Lingard L, Levinson W. Critically appraising qualitative research. BMJ. 2008;337:a1035.","journal-title":"BMJ."},{"issue":"3","key":"2298_CR56","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.ajkd.2014.02.026","volume":"64","author":"A Tong","year":"2014","unstructured":"Tong A, Winkelmayer WC, Craig JC. Qualitative research in CKD: an overview of methods and applications. Am J Kidney Dis. 2014;64(3):338\u201346.","journal-title":"Am J Kidney Dis"},{"key":"2298_CR57","doi-asserted-by":"crossref","unstructured":"Chapelle O, Metlzer D, Zhang Y, Grinspan P. Expected reciprocal rank for graded relevance. In: 18th ACM conference on information and knowledge management 2009. New York: ACM; 2009:621\u2013630.","DOI":"10.1145\/1645953.1646033"},{"key":"2298_CR58","doi-asserted-by":"crossref","first-page":"a288","DOI":"10.1136\/bmj.a288","volume":"337","author":"A Kuper","year":"2008","unstructured":"Kuper A, Reeves S, Levinson W. An introduction to reading and appraising qualitative research. BMJ. 2008;337:a288.","journal-title":"BMJ."},{"issue":"6","key":"2298_CR59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"3","key":"2298_CR60","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2215\/CJN.08370816","volume":"12","author":"A Tong","year":"2017","unstructured":"Tong A, Winkelmayer WC, Wheeler DC, van Biesen W, Tugwell P, Manns B, Hemmelgarn B, Harris T, Crowe S, Ju A, et al. Nephrologists\u2019 perspectives on defining and applying patient-centered outcomes in hemodialysis. Clin J Am Soc Nephrol. 2017;12(3):454\u201366.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2298_CR61","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s13063-015-0905-9","volume":"16","author":"B Blackwood","year":"2015","unstructured":"Blackwood B, Ringrow S, Clarke M, Marshall J, Rose L, Williamson P, McAuley D. Core Outcomes in Ventilation Trials (COVenT): protocol for a core outcome set using a Delphi survey with a nested randomised trial and observational cohort study. Trials. 2015;16:368.","journal-title":"Trials."},{"key":"2298_CR62","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13063-015-0598-0","volume":"16","author":"S MacLennan","year":"2015","unstructured":"MacLennan S, Bekema HJ, Williamson PR, Campbell MK, Stewart F, MacLennan SJ, N'Dow JM, Lam TB. A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey. Trials. 2015;16:76.","journal-title":"Trials."},{"issue":"9","key":"2298_CR63","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00586-015-3984-0","volume":"24","author":"A Chiarotto","year":"2015","unstructured":"Chiarotto A, Deyo RA, Terwee CB, Boers M, Buchbinder R, Corbin TP, Costa LO, Foster NE, Grotle M, Koes BW, et al. Erratum to: Core outcome domains for clinical trials in non-specific low back pain. Eur Spine J. 2015;24(9):2097.","journal-title":"Eur Spine J"},{"issue":"6","key":"2298_CR64","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00586-015-3892-3","volume":"24","author":"A Chiarotto","year":"2015","unstructured":"Chiarotto A, Deyo RA, Terwee CB, Boers M, Buchbinder R, Corbin TP, Costa LO, Foster NE, Grotle M, Koes BW, et al. Core outcome domains for clinical trials in non-specific low back pain. Eur Spine J. 2015;24(6):1127\u201342.","journal-title":"Eur Spine J"},{"issue":"4","key":"2298_CR65","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/j.ajkd.2016.11.029","volume":"70","author":"N Evangelidis","year":"2017","unstructured":"Evangelidis N, Tong A, Manns B, Hemmelgarn B, Wheeler DC, Tugwell P, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, et al. Developing a set of core outcomes for trials in hemodialysis: an international Delphi survey. Am J Kidney Dis. 2017;70(4):464\u201375.","journal-title":"Am J Kidney Dis"},{"key":"2298_CR66","doi-asserted-by":"crossref","first-page":"0875","DOI":"10.1097\/TP.0000000000001776","volume":"101","author":"B Sautenet","year":"2017","unstructured":"Sautenet B, Tong A, Manera KE, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J, Budde K, Rostaing L, et al. Developing consensus-based priority outcome domains for trials in kidney transplantation: a multinational Delphi survey with patients, caregivers and health professionals. Transplantation. 2017;101:0875\u20131886.","journal-title":"Transplantation."},{"key":"2298_CR67","unstructured":"Schunemann H, Brozek J, Oxman A, editors. GRADE handbook for grading quality of evidence and strength of recommendations. Version 3.2 [updated March 2009]. The GRADE Working Group, 2009. Available from \nhttp:\/\/www.cc-ims-net\/gradepro\n\n."},{"key":"2298_CR68","doi-asserted-by":"crossref","unstructured":"Cheung KL, Wijnen BFM, Hollin IL, Janssen EM, Bridges JF, Evers SMAA, Hiligsmann M. Using best\u2013worst scaling to investigate preferences in health care. Pharmacoeconomics. 2016;34(12):1195\u2013209.","DOI":"10.1007\/s40273-016-0429-5"},{"issue":"8","key":"2298_CR69","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/TP.0000000000001774","volume":"101","author":"A Tong","year":"2017","unstructured":"Tong A, Gill J, Budde K, Marson L, Reese PP, Rosenbloom D, Rostaing L, Wong G, Josephson MA, Pruett TL, et al. Toward establishing core outcome domains for trials in kidney transplantation: report of the standardized outcomes in nephrology-kidney transplantation consensus workshops. Transplantation. 2017;101(8):1887\u201396.","journal-title":"Transplantation"},{"issue":"10","key":"2298_CR70","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1007\/s11999-010-1380-y","volume":"468","author":"S Badarudeen","year":"2010","unstructured":"Badarudeen S, Sabharwal S. Assessing readability of patient education materials: current role in orthopaedics. Clin Orthop Relat Res. 2010;468(10):2572\u201380.","journal-title":"Clin Orthop Relat Res"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2298-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T06:58:32Z","timestamp":1511420312000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2298-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,23]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2298"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2298-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,23]]},"article-number":"560"}}